Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, I was talking about how Professor Richard Marmalade Pestell could pull off the biggest scam share heist in the history of the company, do nothing as CMO, and still be consider a good guy with people wishing he had never left.
$CRTD closed 93c, hod. Maybe we see a $1 push Monday.
$CRTD 90c, getting close
Sure,
1) NP didn't need to run a pump and dump to get rich. He made millions in salary already as CEO. He also didn't sell 85% of his holdings. He was to be awarded million more later in 2020 (the reason I left). There was no need, incentive or motive for him to.
2 NP didn't need to pump the stock on fake BLA filing news. The share price was multiples of what he sold it several times over the next year. Early April we have results with leronlimab with Covid showed it working with emergency patients. People were getting up off ventilators after given shots. There were experts in the field saying Covid was a Rantes disease. Cancer looked good, HIV approval was coming, Covid look great. One reason the stock price was so high in 2020 and 2021. There was no need to pump the stock price to sell into. And no reason to think the share price wouldn't keep going up when he sold... and it did for quite a while after he sold.
Thank you; I appreciate the details you gave for the case against NP. I've not followed it really. I was going to counter with why I thought he defense might be, but I'm wasting time here today instead of making money trading. Maybe on the other board when I get time... thanks.
We originally thought the BLA would be done in 2016. I’m don’t remember when they originally started l, maybe 2027 or 2018. At one point In 2019 or maybe 2020, I remember him saying they were paying everyone overtime to get it done. Maybe he thought they were milking it and calling bullshit. How many years does it take. Or maybe as I said he wanted it done for emergency approval for covid. But selling stock right after is a bad look, definitely.
Listen, I couldn’t care less one way or another. If he is guilty, he is guilty. But you guys have found him guilty already and I sense a strong bias to that fact. That’s not how it works here in America.
$CRTD 80
$CRTD, 72c, wow, crazy move today
We will see. I think you underestimate him. He won the 2001 Indian Arts craft case because he was "technically correct". He did have a Native American on staff. They had to drop the case. The direct quote they complained about I believe was technically correct... just saying. I read this case back in 2017, and after that I followed his words closely. He always worded stuff that was technically correct from when I followed it. Did you leave out the p-value for he overall trial didn't meet statistical significance. Yes, he always left out the bad news. I use to say NP doesn't like giving bad news. But the good news was always correctly worded in my opinion.
His argument
Yeah that vote on compensation is when when I first thought that myself...too much greed was showing for me to stay back then. When NP left, it actually became more interesting for me again because of that.
I originally quietly left Oct 1 2020, because of this below. I could not believe this got approved. I didn't vote no, I voted hell no. I could not believe they increased the OS and then asked for 25M shares of stock options when they were awaiting awarding 8M of those already at the current price, I believe around $3. But I have a little now. As I just read your last post yesterday, I agree fairly close to your assessment, it is the science vs the financial situation. The price is what it is because of the latter issue. I follow to see if the science ever makes a come back.
If that’s true it should be an open and shut case. There’s lies, damn lies, and then there are statistics. I always found his PRs to be technically accurate. I just read the FDA complaint. And I believe he might be technically accurate there as well. He was comparing stats in a sub population of the trial, critical and those on ventilators. The issue is that sub population was not randomly assigned, so you can’t just compare numbers from a sub population. you would need a new trial to verify.
Another example, I followed the mono numbers. I believe his stats where also true, but he started focusing on after week 10, there was a 90% success… well you need to include week 1-9 to get the full stat, but the stat was accurate.
Basically NP did a pump and dump, knew leronlimab was a scam that wouldn’t be approved. He filed an incomplete BLA to pump the stock so he could dump his shares.
Maybe,
Mine. Early result for Covid looked amazing. NP really thought leronlimab was the treatment for Covid. Thought they would get emergency approval if the BLA was filed and manufacturing in place, he would fix the BLA for HIV later, use the 6M or whatever the company got from his stock exercise to push the manufacturing. It should be easily for the investigation to find out that. Made a huge bet on manufacturing that haunts the company to this day. One I doubt someone that wasn’t expecting approval or was scamming false hope would make really.
It wouldn’t bother me either way, but we will see which version is correct hopefully. Could be a mixture.
You are missing one key point... We will see who is right. I actually hope you are... in will run sooner.
I understand you seeing it that way. My view of NP is different. I felt he was very caring and passionate for leronlimab. The felonies didn't bother me, I researched them. Same with teaching he did have a PhD. I read through his book also and he came to some enlightenments I thought. My view was he was caring and passionate, but also bull headed, impatient, and got too greedy, plus yeah the inexperience with the FDA didn't help... he didn't have the FDA cheat codes BP has. Telling Amarex to submit the BLA to me was probably like telling Pestell to submit the protocol. He was tired of waiting and waiting and wanted it done, and done his way. I actually agree with him on the Pestell issue, but the BLA was a bad call. Of course, just my opinion, watching him for years. I understand if others come to different conclusions on him. But yeah, hopefully they move to oncology, where I think they will find success, though it might take time for approval. I was hoping they could piggyback off of HIV approval and have some off-label oncology sales before the official approval.
This will run, but Apollo isn't fully loaded yet, see below. The remaining 10M shares are for them also, imo, to cover their continuing option (32% discount at 25% on a $400,000 option is 5M shares). Do that twice and voila 10M shares. In the mean time, I wait and add any big dips if they decide to sell some to get the Nov 14 option cheaper or be happy to watch it run once it starts.
Yeah, NP played a big role in the failure as well with the BLA, getting on the bad side of the FDA. But the FDA greatly hurt. In my opinion, if the FDA wanted it approved, it would be approved. Specifically their restrictions were so strict it too forever to get the trail filled. Then the added additional safety requirements. The the dose change talk different than the trial. Then they added a RO requirement. None of that was needed if you are hit 80% when the previous approval was below 50% with this population in my opinion, especially given the safety history. Again, JMO.
Not surprising, remember this is what it took the first time to get some critical AIDS patients drugs through the FDA process, but they have went back to small trials over a long number of years here it seems and little experimental access to the MDR2 or MDR3 HIV groups. Sad, I agree HIV may be lost. But remember in other areas, cancer, nash for example, there are more BPs, not just CYDY, with trials researching the CCR5 connection. So a much better chance for approval in these in my opinion. Again, all, JMO.
"RIP killed by the FDA" "Dead from the FDA Red Tape", "Stop killing us!"
https://www.npr.org/sections/health-shots/2019/02/09/689924838/how-to-demand-a-medical-breakthrough-lessons-from-the-aids-fight
$CRTD 62c, new high
$SHMP merger with Nasdaq Yotta, 13c
$ABML 82c, another HOD at end of day. This might hit dollar land unicorn status again
Only if you don’t like making money
$ABML hod on nice news this morning.
$CRTD, hit almost 40c today. A few runners finally, ABML was a good one this morning also... OTC getting some life back.